Report: Drug-device combo market is poised for robust growth

12/26/2013 | Medical Device & Diagnostic Industry online

A Transparency Market Research report forecasts that the worldwide market for drug-device combination products such as drug-eluting stents, bone grafts and infusion pumps will increase from $66 billion in 2012 to $115.1 billion by 2019. Growth will be driven in part by the rising number of chronic obstructive pulmonary disease, asthma and cardiovascular disease cases, the report notes.

View Full Article in:

Medical Device & Diagnostic Industry online

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Director of Program Development
AdvaMed
Washington DC, DC
Director of System QA
LifeWatch Services, Inc.
Rosemont, IL
Director of Business Development and Membership
AdvaMed
Washington DC, DC
Director, Corporate Counsel
Regeneron
Tarrytown, NY